TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M.M., PASTAN, I., WILLINGHAM, M.C.,
1987. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal
human tissues. Proc. Natl. Acad. Sci. U.S.A. 84: 7735–7738.
THOMAS, W.E., 1999. Brain macrophages: on the role of pericytes and perivascular cells. Brain Res
Rev. 31: 42-57.
THOMAS, H., COLEY, H.M., 2003. Overcoming multidrug resistance in cancer: an update on the
clinical strategy of inhibiting p-glycoprotein. Cancer Control 10: 159 –165.
TIMSIT, Y.E., NEGISHI, M., 2007. CAR and PXR: the xenobiotic-sensing receptors. Steroids 72: 231-
46.
TISHLER, D.M., WEINBERG, K.I., HINTON, D.R., BARBARO, N., ANNETT, G.M., RAFFEL, C., 1995.
MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36: 1-
6.
TROUTMAN, M.D., THAKKER, D.R., 2003. Rhodamine 123 requires carrier-mediated influx for its
activity as a P-glycoprotein substrate in Caco-2 cells. Pharm Res. 20: 1192-9.
TSUJI, A., TAMAI, I., 1999. Carrier-mediated or specialized transport of drugs across the bloodbrain
barrier. Adv Drug Deliv Rev. 36: 277-290.
URICH, E., LAZIC, S.E., MOLNOS, J., WELLS, I., FRESKGÅRD, P.O., 2012. Transcriptional profiling
of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain
barrier models. PloS One. 7(5):e38149.
VAN DORPE, S., BRONSELAER, A., NIELANDT, J., STALMANS, S., WYNENDAELE, E.,
AUDENAERT, K., VAN DE WIELE, C., BURVENICH, C., PEREMANS, K., HSUCHOU, H., DE
TRÉ, G., DE SPIEGELEER, B., 2012. Brainpeps: the blood-brain barrier peptide database.
Brain Struct Funct. 217: 687-718.
VAN VLIET, E.A., VAN SCHAIK, R., EDELBROEK, P.M., REDEKER, S., ARONICA, E., WADMAN,
W.J., MARCHI, N, VEZZANI, A., GORTER, J.A., 2006. Inhibition of the multidrug transporter
P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia.
47: 672-80.
VAN VLIET, E.A., VAN SCHAIK, R., EDELBROEK, P.M., VOSKUYL, R.A., REDEKER, S., ARONICA,
E., WADMAN, W.J., GORTER, J.A., 2007. Region-specific overexpression of P-glycoprotein
at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats. J Pharmacol Exp
Ther. 322: 141–147.
VANTELON, N., RIOUX-BILAN, A., INGRAND, S., PAIN, S., PAGE, G., GUILLARD, O., BARRIER, L.,
PIRIOU, A., FAUCONNEAU, B., 2007. Regulation of initiation factors controlling protein
synthesis on cultured astrocytes in lactic acid-induced stress. Eur J Neurosci. 26: 689-700.
VERGONI, A.V., TOSI, G., TACCHI, R., VANDELLI, M.A., BERTOLINI, A., COSTANTINO, L., 2009.
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. Nanomedicine
5: 369-377.
VOLK, H.A., BURKHARDT, K., POTSCHKA, H., CHEN, J., BECKER, A., LÖSCHER, W., 2004a.
Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after
limbic seizures. Neuroscience 123: 751–759.
202